Pharmacokinetics (pk) of Pertuzumab (p) with Trastuzumab (t) and Docetaxel (d) in Her2-positive First-line Metastatic Breast Cancer (mbc): Results From the Phase III Trial Cleopatra

J Cortes; S Swain; I Kudaba; M Hauschild; T Patel; E Grincuka; N Masuda; V McNally; J Visich; J Baselga

Pharmacokinetics (pk) of Pertuzumab (p) with Trastuzumab (t) and Docetaxel (d) in Her2-positive First-line Metastatic Breast Cancer (mbc): Results From the Phase III Trial Cleopatra

J Cortes
, S Swain
, I Kudaba
, M Hauschild
, T Patel
, E Grincuka
, N Masuda
, V McNally
, J Visich
, J Baselga

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	124-125
Number of pages	2
Journal	Annals of Oncology
Volume	23
Issue number	Suppl.9
Publication status	Published - Sept 2012
Externally published	Yes
Event	37th Congress of the European Society for Medical Oncology - Vienna, Austria Duration: 28 Sept 2012 → 2 Oct 2012 Conference number: 37 https://infoscience.epfl.ch/entities/event/0ab6eef0-6329-4116-a6c2-d94140e29b71

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Field of Science*

3.2 Clinical medicine

Publication Type*

3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Cite this

@article{249c484b93a543f18920bac341ca9ffa,

title = "Pharmacokinetics (pk) of Pertuzumab (p) with Trastuzumab (t) and Docetaxel (d) in Her2-positive First-line Metastatic Breast Cancer (mbc): Results From the Phase III Trial Cleopatra",

author = "J Cortes and S Swain and I Kudaba and M Hauschild and T Patel and E Grincuka and N Masuda and V McNally and J Visich and J Baselga",

year = "2012",

month = sep,

language = "English",

volume = "23",

pages = "124--125",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd.",

number = "Suppl.9",

note = "37th Congress of the European Society for Medical Oncology, ESMO ; Conference date: 28-09-2012 Through 02-10-2012",

url = "https://infoscience.epfl.ch/entities/event/0ab6eef0-6329-4116-a6c2-d94140e29b71",

}

TY - JOUR

T1 - Pharmacokinetics (pk) of Pertuzumab (p) with Trastuzumab (t) and Docetaxel (d) in Her2-positive First-line Metastatic Breast Cancer (mbc)

T2 - 37th Congress of the European Society for Medical Oncology

AU - Cortes, J

AU - Swain, S

AU - Kudaba, I

AU - Hauschild, M

AU - Patel, T

AU - Grincuka, E

AU - Masuda, N

AU - McNally, V

AU - Visich, J

AU - Baselga, J

N1 - Conference code: 37

PY - 2012/9

Y1 - 2012/9

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=rsu_pure_&SrcAuth=WosAPI&KeyUT=WOS:000309409000338&DestLinkType=FullRecord&DestApp=WOS

UR - https://www-webofscience-com.db.rsu.lv/wos/alldb/full-record/WOS:000309409000338

M3 - Meeting Abstract

SN - 0923-7534

VL - 23

SP - 124

EP - 125

JO - Annals of Oncology

JF - Annals of Oncology

IS - Suppl.9

Y2 - 28 September 2012 through 2 October 2012

ER -

Pharmacokinetics (pk) of Pertuzumab (p) with Trastuzumab (t) and Docetaxel (d) in Her2-positive First-line Metastatic Breast Cancer (mbc): Results From the Phase III Trial Cleopatra

UN SDGs

Field of Science*

Publication Type*

Other files and links

Cite this